デフォルト表紙
市場調査レポート
商品コード
1460101

末梢神経刺激装置市場の予測:~2030年

Peripheral Nerve Stimulator Market Research Report Forecast till 2030

出版日: | 発行: Market Research Future | ページ情報: 英文 124 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=149.25円
末梢神経刺激装置市場の予測:~2030年
出版日: 2024年03月29日
発行: Market Research Future
ページ情報: 英文 124 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の末梢神経刺激装置の市場規模は、予測期間中にCAGR 6.65%を記録すると予測されています。同市場は、遠隔末梢神経刺激装置への関心が高まっていることから、成長を遂げています。

北米地域市場は有望であり、市場の発展が期待されます。医療基盤への関心と最先端の臨床アレンジメントに対する意識の拡大が、市場のさらなる成長を促進すると思われます。また、欧州市場は、技術革新の進歩、医療サービス使用の拡大、症例数の増加により、業界全体で第2位のシェアを占めました。さらに、アジア太平洋市場は、人口の多さ、神経血管感染症の増加、優れた管理戦略により、最大の市場になると見込まれています。また、世界の末梢神経刺激装置市場で活躍する中心的企業がこの地域に効果的に進出しており、地域市場の発展をさらに促進しています。

当レポートでは、世界の末梢神経刺激装置の市場を調査し、市場の定義と概要、市場成長への影響因子および市場機会の分析、市場規模の推移・予測、各種区分・地域別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 エグゼクティブサマリー

第2章 エグゼクティブサマリー

第3章 市場概要

第4章 調査手法

第5章 市場力学

  • 概要
  • 促進要因
    • 末梢神経刺激装置の需要の増加
    • 神経損傷の増加
    • ワイヤレス末梢神経刺激装置の需要の増加
  • 抑制要因
    • デバイスのインストールと制御に関する技術的スキルの欠如
    • 末梢神経刺激装置に関連する高コスト性
  • 機会
    • 技術の進歩の進展

第6章 市場要因分析

  • バリューチェーン分析
  • ポーターのファイブフォース分析
  • COVID-19が世界の末梢神経刺激装置市場に与える影響

第7章 世界の末梢神経刺激装置市場:製品別

  • 概要
  • 経皮的 (transcutaneous法)
  • 経皮的 (percutaneous法)
  • 埋め込み式

第8章 世界の末梢神経刺激装置市場:デバイスタイプ別

  • 概要
  • 刺激装置
  • CPNBカテーテル
  • ペインポンプ
  • その他

第9章 世界の末梢神経刺激装置市場:刺激特性別

  • 概要
  • 4連(TOF)モニタリング機能を備えた刺激装置
  • TOF機能のないマシン

第10章 世界の末梢神経刺激装置市場:エンドユーザー別

  • 概要
  • 病院・クリニック
  • 外来手術センター
  • その他

第11章 世界の末梢神経刺激装置市場:地域別

  • 概要
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第12章 企業プロファイル

  • 概要
  • 競合ベンチマーキング
  • 主要な成長戦略
  • 開発件数でトップの企業
  • 主要開発分析
  • 主な展開・成長戦略
  • 財務マトリックス

第13章 企業プロファイル

  • MEDTRONIC
  • B. BRAUN SE
  • BOSTON SCIENTIFIC CORPORATION
  • CURONIX LLC
  • SPR THERAPEUTICS
  • AVNS
  • TELEFLEX INCORPORATED
  • SUNMED
  • XAVANT TECHNOLOGY(PTY)LTD
  • VYGON

第14章 付録

図表

LIST OF TABLES

  • TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
  • TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
  • TABLE 3 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 4 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, FOR TRANSCUTANEOUS, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 5 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, FOR PERCUTANEOUS, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 6 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, FOR IMPLANTABLE, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 7 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, BY DEVICE TYPE, 2019-2030 (USD MILLION)
  • TABLE 8 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, FOR STIMULATORS, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 9 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, FOR CPNB CATHETERS, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 10 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, FOR PAIN PUMPS, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 11 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, FOR OTHERS, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 12 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, BY STIMULATING FEATURE, 2019-2030 (USD MILLION)
  • TABLE 13 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, FOR STIMULATOR MACHINES WITH TRAIN OF FOUR (TOF) MONITORING FEATURES, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 14 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, FOR MACHINES WITHOUT TOF FEATURES, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 15 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 16 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, FOR HOSPITALS & CLINICS, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 17 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, FOR AMBULATORY SURGERY CENTERS, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 18 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, FOR OTHERS, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 19 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 20 GLOBAL: PERIPHERAL NERVE STIMULATORS MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 21 GLOBAL: PERIPHERAL NERVE STIMULATORS MARKET, BY DEVICE TYPE, 2019-2030 (USD MILLION)
  • TABLE 22 GLOBAL: PERIPHERAL NERVE STIMULATORS MARKET, BY STIMULATING FEATURE, 2019-2030 (USD MILLION)
  • TABLE 23 GLOBAL: PERIPHERAL NERVE STIMULATORS MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 24 NORTH AMERICA: PERIPHERAL NERVE STIMULATORS MARKET, BY COUNTRY, 2019-2030 (USD MILLION)
  • TABLE 25 NORTH AMERICA: PERIPHERAL NERVE STIMULATORS MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 26 NORTH AMERICA: PERIPHERAL NERVE STIMULATORS MARKET, BY DEVICE TYPE, 2019-2030 (USD MILLION)
  • TABLE 27 NORTH AMERICA: PERIPHERAL NERVE STIMULATORS MARKET, BY STIMULATING FEATURE, 2019-2030 (USD MILLION)
  • TABLE 28 NORTH AMERICA: PERIPHERAL NERVE STIMULATORS MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 29 US: PERIPHERAL NERVE STIMULATORS MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 30 US: PERIPHERAL NERVE STIMULATORS MARKET, BY DEVICE TYPE, 2019-2030 (USD MILLION)
  • TABLE 31 US: PERIPHERAL NERVE STIMULATORS MARKET, BY STIMULATING FEATURE, 2019-2030 (USD MILLION)
  • TABLE 32 US: PERIPHERAL NERVE STIMULATORS MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 33 CANADA: PERIPHERAL NERVE STIMULATORS MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 34 CANADA: PERIPHERAL NERVE STIMULATORS MARKET, BY DEVICE TYPE, 2019-2030 (USD MILLION)
  • TABLE 35 CANADA: PERIPHERAL NERVE STIMULATORS MARKET, BY STIMULATING FEATURE, 2019-2030 (USD MILLION)
  • TABLE 36 CANADA: PERIPHERAL NERVE STIMULATORS MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 37 EUROPE: PERIPHERAL NERVE STIMULATORS MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 38 EUROPE: PERIPHERAL NERVE STIMULATORS MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 39 EUROPE: PERIPHERAL NERVE STIMULATORS MARKET BY DEVICE TYPE, 2019-2030 (USD MILLION)
  • TABLE 40 EUROPE: PERIPHERAL NERVE STIMULATORS MARKET, BY STIMULATING FEATURE, 2019-2030 (USD MILLION)
  • TABLE 41 EUROPE: PERIPHERAL NERVE STIMULATORS MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 42 GERMANY: PERIPHERAL NERVE STIMULATORS MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 43 GERMANY: PERIPHERAL NERVE STIMULATORS MARKET BY DEVICE TYPE, 2019-2030 (USD MILLION)
  • TABLE 44 GERMANY: PERIPHERAL NERVE STIMULATORS MARKET, BY STIMULATING FEATURE, 2019-2030 (USD MILLION)
  • TABLE 45 GERMANY: PERIPHERAL NERVE STIMULATORS MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 46 FRANCE: PERIPHERAL NERVE STIMULATORS MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 47 FRANCE: PERIPHERAL NERVE STIMULATORS MARKET BY DEVICE TYPE, 2019-2030 (USD MILLION)
  • TABLE 48 FRANCE: PERIPHERAL NERVE STIMULATORS MARKET, BY STIMULATING FEATURE, 2019-2030 (USD MILLION)
  • TABLE 49 FRANCE: PERIPHERAL NERVE STIMULATORS MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 50 UK: PERIPHERAL NERVE STIMULATORS MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 51 UK: PERIPHERAL NERVE STIMULATORS MARKET BY DEVICE TYPE, 2019-2030 (USD MILLION)
  • TABLE 52 UK: PERIPHERAL NERVE STIMULATORS MARKET, BY STIMULATING FEATURE, 2019-2030 (USD MILLION)
  • TABLE 53 UK: PERIPHERAL NERVE STIMULATORS MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 54 ITALY: PERIPHERAL NERVE STIMULATORS MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 55 ITALY: PERIPHERAL NERVE STIMULATORS MARKET BY DEVICE TYPE, 2019-2030 (USD MILLION)
  • TABLE 56 ITALY: PERIPHERAL NERVE STIMULATORS MARKET, BY STIMULATING FEATURE, 2019-2030 (USD MILLION)
  • TABLE 57 ITALY: PERIPHERAL NERVE STIMULATORS MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 58 SPAIN: PERIPHERAL NERVE STIMULATORS MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 59 SPAIN: PERIPHERAL NERVE STIMULATORS MARKET BY DEVICE TYPE, 2019-2030 (USD MILLION)
  • TABLE 60 SPAIN: PERIPHERAL NERVE STIMULATORS MARKET, BY STIMULATING FEATURE, 2019-2030 (USD MILLION)
  • TABLE 61 SPAIN: PERIPHERAL NERVE STIMULATORS MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 62 REST OF EUROPE: PERIPHERAL NERVE STIMULATORS MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 63 REST OF EUROPE: PERIPHERAL NERVE STIMULATORS MARKET BY DEVICE TYPE, 2019-2030 (USD MILLION)
  • TABLE 64 REST OF EUROPE: PERIPHERAL NERVE STIMULATORS MARKET, BY STIMULATING FEATURE, 2019-2030 (USD MILLION)
  • TABLE 65 REST OF EUROPE: PERIPHERAL NERVE STIMULATORS MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 66 ASIA-PACIFIC: PERIPHERAL NERVE STIMULATORS MARKET, BY COUNTRY, 2019-2030 (USD MILLION)
  • TABLE 67 ASIA-PACIFIC: PERIPHERAL NERVE STIMULATORS MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 68 ASIA-PACIFIC: PERIPHERAL NERVE STIMULATORS MARKET, BY DEVICE TYPE, 2019-2030 (USD MILLION)
  • TABLE 69 ASIA-PACIFIC: PERIPHERAL NERVE STIMULATORS MARKET, BY STIMULATING FEATURE, 2019-2030 (USD MILLION)
  • TABLE 70 ASIA-PACIFIC: PERIPHERAL NERVE STIMULATORS MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 71 CHINA: PERIPHERAL NERVE STIMULATORS MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 72 CHINA: PERIPHERAL NERVE STIMULATORS MARKET, BY DEVICE TYPE, 2019-2030 (USD MILLION)
  • TABLE 73 CHINA: PERIPHERAL NERVE STIMULATORS MARKET, BY STIMULATING FEATURE, 2019-2030 (USD MILLION)
  • TABLE 74 CHINA: PERIPHERAL NERVE STIMULATORS MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 75 INDIA: PERIPHERAL NERVE STIMULATORS MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 76 INDIA: PERIPHERAL NERVE STIMULATORS MARKET, BY DEVICE TYPE, 2019-2030 (USD MILLION)
  • TABLE 77 INDIA: PERIPHERAL NERVE STIMULATORS MARKET, BY STIMULATING FEATURE, 2019-2030 (USD MILLION)
  • TABLE 78 INDIA: PERIPHERAL NERVE STIMULATORS MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 79 JAPAN: PERIPHERAL NERVE STIMULATORS MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 80 JAPAN: PERIPHERAL NERVE STIMULATORS MARKET, BY DEVICE TYPE, 2019-2030 (USD MILLION)
  • TABLE 81 JAPAN: PERIPHERAL NERVE STIMULATORS MARKET, BY STIMULATING FEATURE, 2019-2030 (USD MILLION)
  • TABLE 82 JAPAN: PERIPHERAL NERVE STIMULATORS MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 83 SOUTH KOREA: PERIPHERAL NERVE STIMULATORS MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 84 SOUTH KOREA: PERIPHERAL NERVE STIMULATORS MARKET, BY DEVICE TYPE, 2019-2030 (USD MILLION)
  • TABLE 85 SOUTH KOREA: PERIPHERAL NERVE STIMULATORS MARKET, BY STIMULATING FEATURE, 2019-2030 (USD MILLION)
  • TABLE 86 SOUTH KOREA: PERIPHERAL NERVE STIMULATORS MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 87 AUSTRALIA: PERIPHERAL NERVE STIMULATORS MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 88 AUSTRALIA: PERIPHERAL NERVE STIMULATORS MARKET, BY DEVICE TYPE, 2019-2030 (USD MILLION)
  • TABLE 89 AUSTRALIA: PERIPHERAL NERVE STIMULATORS MARKET, BY STIMULATING FEATURE, 2019-2030 (USD MILLION)
  • TABLE 90 AUSTRALIA: PERIPHERAL NERVE STIMULATORS MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 91 REST OF ASIA-PACIFIC: PERIPHERAL NERVE STIMULATORS MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 92 REST OF ASIA-PACIFIC: PERIPHERAL NERVE STIMULATORS MARKET, BY DEVICE TYPE, 2019-2030 (USD MILLION)
  • TABLE 93 REST OF ASIA-PACIFIC: PERIPHERAL NERVE STIMULATORS MARKET, BY STIMULATING FEATURE, 2019-2030 (USD MILLION)
  • TABLE 94 REST OF ASIA-PACIFIC: PERIPHERAL NERVE STIMULATORS MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 1 REST OF THE WORLD: PERIPHERAL NERVE STIMULATORS MARKET, BY COUNTRY, 2019-2030 (USD MILLION)
  • TABLE 2 REST OF THE WORLD: PERIPHERAL NERVE STIMULATORS MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 3 REST OF THE WORLD: PERIPHERAL NERVE STIMULATORS MARKET, BY DEVICE TYPE, 2019-2030 (USD MILLION)
  • TABLE 4 REST OF THE WORLD: PERIPHERAL NERVE STIMULATORS MARKET, BY STIMULATING FEATURE, 2019-2030 (USD MILLION)
  • TABLE 5 REST OF THE WORLD: PERIPHERAL NERVE STIMULATORS MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 6 MIDDLE EAST: PERIPHERAL NERVE STIMULATORS MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 7 MIDDLE EAST: PERIPHERAL NERVE STIMULATORS MARKET, BY DEVICE TYPE, 2019-2030 (USD MILLION)
  • TABLE 8 MIDDLE EAST: PERIPHERAL NERVE STIMULATORS MARKET, BY STIMULATING FEATURE, 2019-2030 (USD MILLION)
  • TABLE 9 MIDDLE EAST: PERIPHERAL NERVE STIMULATORS MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 10 AFRICA: PERIPHERAL NERVE STIMULATORS MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 11 AFRICA: PERIPHERAL NERVE STIMULATORS MARKET, BY DEVICE TYPE, 2019-2030 (USD MILLION)
  • TABLE 12 AFRICA: PERIPHERAL NERVE STIMULATORS MARKET, BY STIMULATING FEATURE, 2019-2030 (USD MILLION)
  • TABLE 13 AFRICA: PERIPHERAL NERVE STIMULATORS MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 14 LATIN AMERICA: PERIPHERAL NERVE STIMULATORS MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 15 LATIN AMERICA: PERIPHERAL NERVE STIMULATORS MARKET, BY DEVICE TYPE, 2019-2030 (USD MILLION)
  • TABLE 16 LATIN AMERICA: PERIPHERAL NERVE STIMULATORS MARKET, BY STIMULATING FEATURE, 2019-2030 (USD MILLION)
  • TABLE 17 LATIN AMERICA: PERIPHERAL NERVE STIMULATORS MARKET, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 18 MAJOR PLAYERS IN THE GLOBAL PERIPHERAL NERVE STIMULATORS MARKET
  • TABLE 19 BENCHMARKING OF MAJOR COMPETITORS
  • TABLE 20 MOST ACTIVE PLAYER IN THE GLOBAL PERIPHERAL NERVE STIMULATORS MARKET
  • TABLE 21 PRODUCT APPROVAL AND PRODUCT LAUNCH: GLOBAL PERIPHERAL NERVE STIMULATORS MARKET
  • TABLE 22 MEDTRONIC: PRODUCTS OFFERED
  • TABLE 23 MEDTRONIC: KEY DEVELOPMENTS
  • TABLE 24 B. BRAUN SE: PRODUCTS OFFERED
  • TABLE 25 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
  • TABLE 26 BOSTON SCIENTIFIC CORPORATION: KEY DEVELOPMENTS
  • TABLE 27 CURONIX LLC: PRODUCTS OFFERED
  • TABLE 28 SPR THERAPEUTICS: PRODUCTS OFFERED
  • TABLE 29 SPR THERAPEUTICS: KEY DEVELOPMENTS
  • TABLE 30 AVNS: PRODUCTS OFFERED
  • TABLE 31 TELEFLEX INCORPORATED: PRODUCTS OFFERED
  • TABLE 32 SUNMED: PRODUCTS OFFERED
  • TABLE 33 XAVANT TECHNOLOGY (PTY) LTD: PRODUCTS OFFERED
  • TABLE 34 XAVANT TECHNOLOGY (PTY) LTD: KEY DEVELOPMENTS
  • TABLE 35 VYGON: PRODUCTS OFFERED

LIST OF FIGURES

  • FIGURE 1 MARKET SYNOPSIS
  • FIGURE 2 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET
  • FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES
  • FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL PERIPHERAL NERVE STIMULATORS MARKET
  • FIGURE 5 DRIVER IMPACT ANALYSIS
  • FIGURE 6 RESTRAINT IMPACT ANALYSIS
  • FIGURE 7 VALUE CHAIN ANALYSIS: GLOBAL PERIPHERAL NERVE STIMULATORS MARKET
  • FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: GLOBAL PERIPHERAL NERVE STIMULATORS MARKET
  • FIGURE 9 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, PRODUCT SEGMENT ATTRACTIVENESS, (USD MILLION)
  • FIGURE 10 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, BY PRODUCT, 2022 & 2030 (USD MILLION)
  • FIGURE 11 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET SHARE (%), BY PRODUCT, 2022
  • FIGURE 12 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, DEVICE TYPE SEGMENT ATTRACTIVENESS, (USD MILLION)
  • FIGURE 13 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, BY DEVICE TYPE, 2022 & 2030 (USD MILLION)
  • FIGURE 14 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET SHARE (%), BY DEVICE TYPE, 2022
  • FIGURE 15 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, STIMULATING FEATURE SEGMENT ATTRACTIVENESS, (USD MILLION)
  • FIGURE 16 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, BY STIMULATING FEATURE, 2022 & 2030 (USD MILLION)
  • FIGURE 17 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET SHARE (%), BY STIMULATING FEATURE, 2022
  • FIGURE 18 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, END USER SEGMENT ATTRACTIVENESS, (USD MILLION)
  • FIGURE 19 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, BY END USER, 2022 & 2030 (USD MILLION)
  • FIGURE 20 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET SHARE (%), BY END USER, 2022
  • FIGURE 21 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, BY REGION, 2021 & 2030 (USD MILLION)
  • FIGURE 22 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET SHARE, BY REGION, 2021 (%)
  • FIGURE 23 NORTH AMERICA MARKET ANALYSIS: PERIPHERAL NERVE STIMULATORS MARKET, 2019-2030 (USD MILLION)
  • FIGURE 24 NORTH AMERICA: PERIPHERAL NERVE STIMULATORS MARKET, BY COUNTRY, 2021 & 2030 (USD MILLION)
  • FIGURE 25 NORTH AMERICA: PERIPHERAL NERVE STIMULATORS MARKET SHARE, BY COUNTRY 2021 (%)
  • FIGURE 26 EUROPE MARKET ANALYSIS: PERIPHERAL NERVE STIMULATORS MARKET, 2019-2030 (USD MILLION)
  • FIGURE 27 EUROPE: PERIPHERAL NERVE STIMULATORS MARKET SHARE (%), BY REGION 2022
  • FIGURE 28 EUROPE: PERIPHERAL NERVE STIMULATORS MARKET, BY REGION 2022 & 2030 (USD MILLION)
  • FIGURE 29 ASIA-PACIFIC MARKET ANALYSIS: PERIPHERAL NERVE STIMULATORS MARKET, 2019-2030 (USD MILLION)
  • FIGURE 30 ASIA-PACIFIC: PERIPHERAL NERVE STIMULATORS MARKET SHARE (%), BY COUNTRY, 2022
  • FIGURE 31 ASIA-PACIFIC: PERIPHERAL NERVE STIMULATORS MARKET, BY COUNTRY, 2022 & 2030 (USD MILLION)
  • FIGURE 32 REST OF THE WORLD MARKET ANALYSIS: PERIPHERAL NERVE STIMULATORS MARKET, 2019-2030 (USD MILLION)
  • FIGURE 1 REST OF THE WORLD: PERIPHERAL NERVE STIMULATORS MARKET, BY COUNTRY, 2022 & 2030
  • FIGURE 2 REST OF THE WORLD: PERIPHERAL NERVE STIMULATORS MARKET SHARE (%), BY REGION, 2022
  • FIGURE 3 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL PERIPHERAL NERVE STIMULATORS MARKET
  • FIGURE 4 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET: COMPETITIVE LANDSCAPE
  • FIGURE 5 SALES 2021
  • FIGURE 6 RESEARCH & DEVELOPMENT EXPENDITURE, 2021
  • FIGURE 7 MEDTRONIC: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 8 MEDTRONIC SWOT ANALYSIS
  • FIGURE 9 B. BRAUN SE: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 10 B. BRAUN SE: SWOT ANALYSIS
  • FIGURE 11 BOSTON SCIENTIFIC CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 12 BOSTON SCIENTIFIC CORPORATION: SWOT ANALYSIS
  • FIGURE 13 AVNS: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 14 AVNS: SWOT ANALYSIS
  • FIGURE 15 TELEFLEX INCORPORATED: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 16 TELEFLEX INCORPORATED: SWOT ANALYSIS
目次
Product Code: MRFR/HC/6584-CR

Peripheral Nerve Stimulator Market Research Report Forecast till 2032

Download PDF

Market Overview

Global Peripheral Nerve Stimulators market is anticipated to register a CAGR of 6.65% during the review period. The Worldwide Peripheral Nerve Stimulators market is encountering a development because of the rising interest for Remote Peripheral Nerve Stimulators. This inclination for cutting edge, remote arrangements in neuromodulation is driving the market forward and showing an extraordinary pattern in medical care. The flood popular features the significant development direction of the market.

The Peripheral nerve feeling as often as possible alluded to as PNS, is a normally utilized way to deal with treat persistent agony. The development of the peripheral nerve stimulators market is ascribed to the rising interest for peripheral nerve stimulators, ascend in instances of nerve wounds, and the developing interest for remote peripheral nerve stimulators. In any case, the absence of specialized abilities for establishment and control of a gadget, and the significant expense related with the peripheral nerve stimulators gadgets is expected to hamper the market development.

The utilization of oral prescriptions like Pamelor, Sinequan, and Elavil in neurological turmoil patients is related with destructive aftereffects and may likewise prompt dependence on drugs. Consequently, the peripheral nerve stimulator is profoundly liked as an elective agony control choice as it gives compelling treatment over oral meds. It decreases the utilization of opiate sedates and can be embedded in patients which permits them to play out their nonimpact sporting exercises like swimming. The Public Organization of Neurological Issues and Stroke reports that around 50 million Americans are impacted by roughly 600 neurologic problems every year. Neuropathic torment is a pervasive medical problem in most industrialized countries, affecting generally 40%-60% of the old populace and grown-ups around the world.

Market Segmentation

The Global Peripheral Nerve Stimulators segmentation, based on products, includes transcutaneous, percutaneous, and implantable.

Based on device type the market is classified into stimulators, continuous peripheral nerve blocks (CPNB) catheters, and pain pumps.

Based on stimulating machines the Global Peripheral Nerve Stimulators market is divided into stimulator machines with train of four (TOF) monitoring features and machines without TOF features. The end use segment is segmented into hospitals & clinics, ambulatory surgery centers, and others.

Region Insights

The viewpoint for the North America Peripheral Nerve Stimulators market stays promising, with supported development expected. Interests in medical care foundation and a developing consciousness of cutting-edge clinical arrangements are supposed to drive market extension further. Both laid out players and arising contestants are ready to exploit these valuable open doors, utilizing mechanical progressions to satisfy the rising need for further developed nerve stimulators results.

Europe Peripheral Nerve Stimulators market represented the second-biggest portion of the overall industry because of innovation progressions, expanding medical services use, and expanding instances of nerve wounds.

The Asia-Pacific Peripheral Nerve Stimulators market is attributable to register a biggest market owing to a high quiet populace, rising number neurovascular infections, and good administrative strategies. Besides, central members working in the Worldwide Peripheral Nerve Stimulators market are effectively venturing into this region, further driving the regional market development.

Major Players

The major companies operating in the Peripheral Nerve Stimulators in market are Braun SE (Germany), MEDTRONIC (Ireland), Boston Scientific Corporation (US), SPR Therapeutics (US), AVNS (US), Teleflex Incorporated (US), Curonix LLC (US), SUNMED (US), Xavant Technology (Pty) Ltd (South Africa), and Vygon (France).

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 EXECUTIVE SUMMARY

  • 2.1 OVERVIEW

3 MARKET INTRODUCTION

  • 3.1 DEFINITION
  • 3.2 SCOPE OF THE STUDY
  • 3.3 RESEARCH OBJECTIVE
  • 3.4 MARKET STRUCTURE
  • 3.5 ASSUMPTIONS & LIMITATIONS

4 RESEARCH METHODOLOGY

  • 4.1 DATA MINING
  • 4.2 SECONDARY RESEARCH
  • 4.3 PRIMARY RESEARCH
  • 4.4 BREAKDOWN OF PRIMARY RESPONDENTS
  • 4.5 FORECASTING TECHNIQUES
  • 4.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
    • 4.6.1 BOTTOM-UP APPROACH
    • 4.6.2 TOP-DOWN APPROACH
  • 4.7 DATA TRIANGULATION
  • 4.8 VALIDATION

5 MARKET DYNAMICS

  • 5.1 OVERVIEW
  • 5.2 DRIVERS
    • 5.2.1 INCREASING DEMAND FOR PERIPHERAL NERVE STIMULATORS
    • 5.2.2 RISE IN CASES OF NERVE INJURIES
    • 5.2.3 GROWING DEMAND FOR WIRELESS PERIPHERAL NERVE STIMULATORS
  • 5.3 RESTRAINTS
    • 5.3.1 LACK OF TECHNICAL SKILLS FOR INSTALLATION AND CONTROL OF A DEVICE
    • 5.3.2 HIGH COST ASSOCIATED WITH THE PERIPHERAL NERVE STIMULATORS DEVICES
  • 5.4 OPPORTUNITIES
    • 5.4.1 GROWING TECHNOLOGICAL ADVANCEMENTS

6 MARKET FACTOR ANALYSIS

  • 6.1 VALUE CHAIN ANALYSIS
    • 6.1.1 R&D & DESIGNING
    • 6.1.2 MANUFACTURING
    • 6.1.3 DISTRIBUTION & SALES
    • 6.1.4 POST-SALES MONITORING
  • 6.2 PORTER'S FIVE FORCES MODEL
    • 6.2.1 THREAT OF NEW ENTRANTS
    • 6.2.2 BARGAINING POWER OF SUPPLIERS
    • 6.2.3 THREAT OF SUBSTITUTES
    • 6.2.4 BARGAINING POWER OF BUYERS
    • 6.2.5 INTENSITY OF RIVALRY
  • 6.3 IMPACT OF COVID-19 ON THE GLOBAL PERIPHERAL NERVE STIMULATORS MARKET
    • 6.3.1 IMPACT ON SUPPLY CHAIN
    • 6.3.2 IMPACT ON PRICING
    • 6.3.1 IMPACT ON REGIONS
    • 6.3.2 IMPACT ON PRODUCTION
    • 6.3.3 IMPACT ON DEMAND-SUPPLY GAP

7 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, BY PRODUCT

  • 7.1 OVERVIEW
  • 7.2 TRANSCUTANEOUS
  • 7.3 PERCUTANEOUS
  • 7.4 IMPLANTABLE

8 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, BY DEVICE TYPE

  • 8.1 OVERVIEW
  • 8.2 STIMULATORS
  • 8.3 CPNB CATHETERS
  • 8.4 PAIN PUMPS
  • 8.5 OTHERS

9 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, BY STIMULATING FEATURE

  • 9.1 OVERVIEW
  • 9.2 STIMULATOR MACHINES WITH TRAIN OF FOUR (TOF) MONITORING FEATURES
  • 9.3 MACHINES WITHOUT TOF FEATURES

10 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, BY END USER

  • 10.1 OVERVIEW
  • 10.2 HOSPITAL & CLINICS
  • 10.3 AMBULATORY SURGERY CENTERS
  • 10.4 OTHERS

11 GLOBAL PERIPHERAL NERVE STIMULATORS MARKET, BY REGION

  • 11.1 OVERVIEW
  • 11.2 NORTH AMERICA
    • 11.2.1 NORTH AMERICA
    • 11.2.2 US
    • 11.2.3 CANADA
  • 11.3 EUROPE
    • 11.3.1 GERMANY
    • 11.3.2 FRANCE
    • 11.3.3 UK
    • 11.3.4 ITALY
    • 11.3.5 SPAIN
    • 11.3.6 REST OF EUROPE
  • 11.4 ASIA-PACIFIC
    • 11.4.1 CHINA
    • 11.4.2 INDIA
    • 11.4.3 JAPAN
    • 11.4.4 SOUTH KOREA
    • 11.4.5 AUSTRALIA
    • 11.4.6 REST OF ASIA-PACIFIC
  • 11.5 REST OF THE WORLD
    • 11.5.1 MIDDLE EAST
    • 11.5.2 AFRICA
    • 11.5.3 LATIN AMERICA
  • 12.1 OVERVIEW
  • 12.2 COMPETITIVE BENCHMARKING
  • 12.3 MAJOR GROWTH STRATEGY IN THE GLOBAL PERIPHERAL NERVE STIMULATORS MARKET
  • 12.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL PERIPHERAL NERVE STIMULATORS MARKET
  • 12.5 KEY DEVELOPMENT ANALYSIS
  • 12.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
    • 12.6.1 PRODUCT APPROVAL AND PRODUCT LAUNCH
  • 12.7 FINANCIAL MATRIX
    • 12.7.1 SALES (USD MILLION), 2021
    • 12.7.2 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2021

13 COMPANY PROFILES

  • 13.1 MEDTRONIC
    • 13.1.1 COMPANY OVERVIEW
    • 13.1.2 FINANCIAL OVERVIEW
    • 13.1.3 PRODUCTS OFFERED
    • 13.1.4 KEY DEVELOPMENTS
    • 13.1.5 SWOT ANALYSIS
    • 13.1.6 KEY STRATEGIES
  • 13.2 B. BRAUN SE
    • 13.2.1 COMPANY OVERVIEW
    • 13.2.2 FINANCIAL OVERVIEW
    • 13.2.3 PRODUCTS OFFERED
    • 13.2.4 KEY DEVELOPMENTS
    • 13.2.5 SWOT ANALYSIS
    • 13.2.6 KEY STRATEGIES
  • 13.3 BOSTON SCIENTIFIC CORPORATION
    • 13.3.1 COMPANY OVERVIEW
    • 13.3.2 FINANCIAL OVERVIEW
    • 13.3.3 PRODUCTS OFFERED
    • 13.3.4 KEY DEVELOPMENTS
    • 13.3.5 SWOT ANALYSIS
    • 13.3.6 KEY STRATEGIES
  • 13.4 CURONIX LLC
    • 13.4.1 COMPANY OVERVIEW
    • 13.4.2 FINANCIAL OVERVIEW
    • 13.4.3 PRODUCTS OFFERED
    • 13.4.4 KEY DEVELOPMENTS
    • 13.4.5 KEY STRATEGIES
  • 13.5 SPR THERAPEUTICS
    • 13.5.1 COMPANY OVERVIEW
    • 13.5.2 FINANCIAL OVERVIEW
    • 13.5.3 PRODUCTS OFFERED
    • 13.5.4 KEY DEVELOPMENTS
    • 13.5.5 KEY STRATEGIES
  • 13.6 AVNS
    • 13.6.1 COMPANY OVERVIEW
    • 13.6.2 FINANCIAL OVERVIEW
    • 13.6.3 PRODUCTS OFFERED
    • 13.6.4 KEY DEVELOPMENTS
    • 13.6.5 SWOT ANALYSIS
    • 13.6.6 KEY STRATEGIES
  • 13.7 TELEFLEX INCORPORATED
    • 13.7.1 COMPANY OVERVIEW
    • 13.7.2 FINANCIAL OVERVIEW
    • 13.7.3 PRODUCTS OFFERED
    • 13.7.4 KEY DEVELOPMENTS
    • 13.7.5 SWOT ANALYSIS
    • 13.7.6 KEY STRATEGIES
  • 13.8 SUNMED
    • 13.8.1 COMPANY OVERVIEWS
    • 13.8.2 FINANCIAL OVERVIEW
    • 13.8.3 PRODUCTS OFFERED
    • 13.8.4 KEY DEVELOPMENTS
    • 13.8.5 KEY STRATEGIES
  • 13.9 XAVANT TECHNOLOGY (PTY) LTD
    • 13.9.1 COMPANY OVERVIEW
    • 13.9.2 FINANCIAL OVERVIEW
    • 13.9.3 PRODUCTS OFFERED
    • 13.9.4 KEY DEVELOPMENTS
    • 13.9.5 KEY STRATEGIES
  • 13.10 VYGON
    • 13.10.1 COMPANY OVERVIEW
    • 13.10.2 FINANCIAL OVERVIEW
    • 13.10.3 PRODUCTS OFFERED
    • 13.10.4 KEY DEVELOPMENTSS
    • 13.10.5 KEY STRATEGIES

14 APPENDIX

  • 14.1 REFERENCES
  • 14.2 THE FOUNDATION FOR PERIPHERAL NEUROPATHY
  • 14.3 PERIPHERAL NERVE SOCIETY (PNS)
  • 14.4 AMERICAN NEUROLOGICAL ASSOCIATION (ANA)
  • 14.5 AMERICAN ASSOCIATION OF NEUROLOGICAL SURGEONS
  • 14.6 AMERICAN SOCIETY FOR PERIPHERAL NERVE (ASPN)
  • 14.7 BRITISH PERIPHERAL NERVE SOCIETY (BPNS)
  • 14.8 PAN AFRICAN ASSOCIATION OF NEUROLOGICAL SCIENCES (PAANS)
  • 14.9 THE NEUROLOGICAL ASSOCIATION OF SOUTH AFRICA (NASA)
  • 4.12 RELATED REPORTS